2022 annual financial data
HCW Biologics 2022 Net margin
Direct answer
Net margin was -221.67%.
Operating income was -15,078,778 USD and net income was -14,900,703 USD.
Operating cash flow was -10,386,110 USD.
Get free HCW Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,722,090 USD
- Operating income
- -15,078,778 USD
- Net income
- -14,900,703 USD
- Operating cash flow
- -10,386,110 USD